Financial Statements
Financial Statements

Bayer Group Consolidated Statements of Changes in Equity

 [Table 23]
 Capital
stock
of Bayer
AG


Capital
reserves
of Bayer
AG


Other
reserves
incl. OCI*



Equity
attributable
to Bayer AG
stockholders


Equity
attributable
to non-controlling
interest
incl. OCI*
Equity





 € million€ million€ million€ million€ million€ million
Dec. 31, 20092,1176,16710,61318,8975418,951
Restatement  (77)(77) (77)
Equity transactions with owners      
Capital increase/decrease      
Dividend payments  (1,158)(1,158)(2)(1,160)
Other changes  (4)(4)(3)(7)
Total comprehensive income**  5655659574
Sep. 30, 20102,1176,1679,93918,2235818,281
 
Dec. 31, 20102,1176,16710,54918,8336318,896
Equity transactions with owners      
Capital increase/decrease      
Dividend payments  (1,240)(1,240)(2)(1,242)
Other changes  (1)(1)21
Total comprehensive income**  1,3571,357(4)1,353
Sep. 30, 20112,1176,16710,66518,9495919,008

2010 figures restated

* OCI = other comprehensive income

** Net of tax

Last updated: October 27, 2011

http://www.stockholders-newsletter-q3-2011.bayer.com/en/changes-in-equity.aspx

Copyright © Bayer AG

Print page

Search

Download Center

Publications

Services

Special Interest